Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Legend Biotech Corp ADR (LEGN)
Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Legend Biotech Corp ADR 2101 COTTONTAIL LANE SOMERSET NJ 08873 USA

www.legendbiotech.com P: 732-317-5050

Description:

Legend Biotech Corporation is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's lead product consist LCAR-B38M/JNJ-4528, which are in clinical stage. Legend Biotech Corporation is based in Cayman Islands.

Key Statistics

Overview:

Market Capitalization, $K 11,845,372
Enterprise Value, $K 11,320,272
Shares Outstanding, K 181,789
Annual Sales, $ 117,010 K
Annual Net Income, $ -446,350 K
Last Quarter Sales, $ 96,010 K
Last Quarter Net Income, $ -62,210 K
EBIT, $ -296,230 K
EBITDA, $ -277,840 K
60-Month Beta -0.02
% of Insider Shareholders 0.02%
% of Institutional Shareholders 49.61%
Float, K 181,753
% Float 99.98%
Short Volume Ratio 0.58

Growth:

1-Year Return 38.98%
3-Year Return 165.85%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.17 on 11/20/23
Latest Earnings Date 03/11/24
Earnings Per Share ttm -0.84
EPS Growth vs. Prev Qtr 37.04%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

LEGN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -40.03%
Return-on-Assets % -26.29%
Profit Margin % -381.46%
Debt/Equity 0.21
Price/Sales 47.99
Price/Cash Flow N/A
Price/Book 8.62
Book Value/Share 8.12
Interest Coverage -1.59
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar